StonvexLoading…
StonvexCore line items from ARQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $120.34M | $108.96M | $99.18M | $102.99M |
Operating Income | $-52.96M | $-1.96M | $-13.34M | $-12.07M |
Net Income | $-52.61M | $-5.11M | $-12.25M | $-8.92M |
EPS (Diluted) | $-1.27 | $-0.14 | $-0.42 | $-0.48 |
Total Assets | $230.58M | $284.37M | $235.50M | $181.16M |
Total Liabilities | $62.62M | $67.09M | $57.10M | $41.19M |
Cash & Equivalents | $6.57M | $13.52M | $45.36M | $66.43M |
Free Cash Flow OCF − CapEx | $-11.31M | $-74.69M | $-44.17M | $-14.97M |
Shares Outstanding | 42.73M | 42.02M | 33.17M | 19.17M |